The Effect of Neuroepo on Cognition in Parkinson’s Disease Patients Is Mediated by Electroencephalogram Source Activity

The Effect of Neuroepo on Cognition in Parkinson’s Disease Patients Is Mediated by Electroencephalogram Source Activity

We report on the quantitative electroencephalogram (qEEG) and cognitive effects of Neuroepo in Parkinson’s disease (PD) from a double-blind safety trial (https://clinicaltrials.gov/, number NCT04110678). Neuroepo is a new erythropoietin (EPO) formulation with a low sialic acid content with satisfact...

Full description

Bibliographic Details
Main Authors: Maria L. Bringas Vega, Ivonne Pedroso Ibáñez, Fuleah A. Razzaq, Min Zhang, Lilia Morales Chacón, Peng Ren, Lidice Galan Garcia, Peng Gan, Trinidad Virues Alba, Carlos Lopez Naranjo, Marjan Jahanshahi, Jorge Bosch-Bayard, Pedro A. Valdes-Sosa
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Neuroscience
Subjects:
Neuroepo
EEG
Parkinson’s disease
source analysis
Canonical Correlation Analysis (CCA)
whitening
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2022.841428/full

Internet

https://www.frontiersin.org/articles/10.3389/fnins.2022.841428/full

Similar Items